EGFR and cancer: In addition, Azuma et al., reported that the enhanced expression of FGFR1 conducted as an escape mechanism for cell survival of Afatinib-resistant cancer cells and may compensate the loss of EGFR-driven signaling pathway (Azuma et al., 2014).